Scientific Advisory Board
LuMind Research Down Syndrome Foundation’s Scientific Advisory Board (SAB) provides guidance for our Foundation, evaluating the most promising lines of discovery in Down syndrome cognition research. Their input ensures that donation dollars are allocated to research that is promising and will likely lead to relevant therapies.
Thanks to our SAB, LuMind RDS has an unprecedented track record of success identifying new areas for investigation and helping to shepherd those discoveries into clinical trials and hopefully one day to FDA approval.
The following individuals participate on the LuMind Research Down Syndrome Foundation’s Scientific Advisory Board:
Chair – Scientific Advisory Board
Chief Scientific Officer
Dr. Harpold serves as the Chair of the Foundation’s Scientific Advisory Board contributing his expertise in neuroscience and biomedical research, drug development and intellectual property issues from academia, the pharmaceutical and biotechnology industries.
Professor and March of Dimes Chair in Molecular and Developmental Biology
Gene Expression Laboratory
Salk Institute for Biological Studies
Dr. Evans is an authority on hormones, both their normal activities and their roles in disease.
Professor, Molecular, Cellular and Developmental Biology
University of Colorado
Dr. Leinwand’s research focus is the genetic manipulation of cardiac and skeletal muscle development and function.
Regents’ Professor of Psychology
University of Arizona
Dr. Nadel studies the role of the hippocampal formation in learning and memory and focuses on its particular role in spatial cognition.
Professor, Department of Physiology
Johns Hopkins University
Dr. Reeves’ research goal is to understand how gene dosage imbalance disrupts development in Down syndrome in order to develop and test potential therapies for specific features of Down syndrome.
Senior Clinical Lecturer, Intellectual Disabilities and Mental Health Sciences Unit
University College London
Dr. Strydom is a clinician and researcher with a focus on cognition and behavior in intellectual disabilities, including Down syndrome.